<VariationArchive VariationID="12395" VariationName="NM_000548.5(TSC2):c.2056_2059dup (p.Ser687fs)" VariationType="Duplication" Accession="VCV000012395" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-02" DateCreated="2013-04-04" MostRecentSubmission="2013-09-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="27434" VariationID="12395">
      <GeneList>
        <Gene Symbol="TSC2" FullName="TSC complex subunit 2" GeneID="7249" HGNC_ID="HGNC:12363" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16p13.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="2047985" stop="2089491" display_start="2047985" display_stop="2089491" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="2097989" stop="2138712" display_start="2097989" display_stop="2138712" Strand="+" />
          </Location>
          <OMIM>191092</OMIM>
          <Haploinsufficiency last_evaluated="2020-06-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TSC2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-06-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=TSC2">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000548.5(TSC2):c.2056_2059dup (p.Ser687fs)</Name>
      <CanonicalSPDI>NC_000016.10:2071892:TACT:TACTTACT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16p13.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="2071892" stop="2071893" display_start="2071892" display_stop="2071893" variantLength="4" positionVCF="2071892" referenceAlleleVCF="C" alternateAlleleVCF="CTACT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="2121893" stop="2121894" display_start="2121893" display_stop="2121894" variantLength="4" positionVCF="2121893" referenceAlleleVCF="C" alternateAlleleVCF="CTACT" />
      </Location>
      <ProteinChange>S638fs</ProteinChange>
      <ProteinChange>S650fs</ProteinChange>
      <ProteinChange>S487fs</ProteinChange>
      <ProteinChange>S698fs</ProteinChange>
      <ProteinChange>S687fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.2071893_2071896dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.2071893_2071896dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.2121894_2121897dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.2121894_2121897dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_005895.1" sequenceAccession="NG_005895" sequenceVersion="1" change="g.27588_27591dup">
            <Expression>NG_005895.1:g.27588_27591dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000548.5" sequenceAccession="NM_000548" sequenceVersion="5" change="c.2056_2059dup" MANESelect="true">
            <Expression>NM_000548.5:c.2056_2059dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000539.2" sequenceAccession="NP_000539" sequenceVersion="2" change="p.Ser687fs">
            <Expression>NP_000539.2:p.Ser687fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001077183.3" sequenceAccession="NM_001077183" sequenceVersion="3" change="c.2056_2059dup">
            <Expression>NM_001077183.3:c.2056_2059dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001070651.1" sequenceAccession="NP_001070651" sequenceVersion="1" change="p.Ser687fs">
            <Expression>NP_001070651.1:p.Ser687fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001114382.3" sequenceAccession="NM_001114382" sequenceVersion="3" change="c.2056_2059dup">
            <Expression>NM_001114382.3:c.2056_2059dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001107854.1" sequenceAccession="NP_001107854" sequenceVersion="1" change="p.Ser687fs">
            <Expression>NP_001107854.1:p.Ser687fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318827.2" sequenceAccession="NM_001318827" sequenceVersion="2" change="c.1945_1948dup">
            <Expression>NM_001318827.2:c.1945_1948dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305756.1" sequenceAccession="NP_001305756" sequenceVersion="1" change="p.Ser650fs">
            <Expression>NP_001305756.1:p.Ser650fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318829.2" sequenceAccession="NM_001318829" sequenceVersion="2" change="c.1909_1912dup">
            <Expression>NM_001318829.2:c.1909_1912dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305758.1" sequenceAccession="NP_001305758" sequenceVersion="1" change="p.Ser638fs">
            <Expression>NP_001305758.1:p.Ser638fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318831.2" sequenceAccession="NM_001318831" sequenceVersion="2" change="c.1456_1459dup">
            <Expression>NM_001318831.2:c.1456_1459dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305760.1" sequenceAccession="NP_001305760" sequenceVersion="1" change="p.Ser487fs">
            <Expression>NP_001305760.1:p.Ser487fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001318832.2" sequenceAccession="NM_001318832" sequenceVersion="2" change="c.2089_2092dup">
            <Expression>NM_001318832.2:c.2089_2092dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001305761.1" sequenceAccession="NP_001305761" sequenceVersion="1" change="p.Ser698fs">
            <Expression>NP_001305761.1:p.Ser698fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363528.2" sequenceAccession="NM_001363528" sequenceVersion="2" change="c.2056_2059dup">
            <Expression>NM_001363528.2:c.2056_2059dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350457.1" sequenceAccession="NP_001350457" sequenceVersion="1" change="p.Ser687fs">
            <Expression>NP_001350457.1:p.Ser687fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370404.1" sequenceAccession="NM_001370404" sequenceVersion="1" change="c.2056_2059dup">
            <Expression>NM_001370404.1:c.2056_2059dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357333.1" sequenceAccession="NP_001357333" sequenceVersion="1" change="p.Ser687fs">
            <Expression>NP_001357333.1:p.Ser687fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001370405.1" sequenceAccession="NM_001370405" sequenceVersion="1" change="c.2056_2059dup">
            <Expression>NM_001370405.1:c.2056_2059dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001357334.1" sequenceAccession="NP_001357334" sequenceVersion="1" change="p.Ser687fs">
            <Expression>NP_001357334.1:p.Ser687fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_021055.3" sequenceAccession="NM_021055" sequenceVersion="3" change="c.2056_2059dup">
            <Expression>NM_021055.3:c.2056_2059dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_066399.2" sequenceAccession="NP_066399" sequenceVersion="2" change="p.Ser687fs">
            <Expression>NP_066399.2:p.Ser687fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_487" sequenceAccession="LRG_487">
            <Expression>LRG_487:g.27588_27591dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_487t1" sequenceAccession="LRG_487t1">
            <Expression>LRG_487t1:c.2056_2059dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA016517" DB="ClinGen" />
        <XRef ID="TSC2_00062" DB="Tuberous sclerosis database (TSC2)" />
        <XRef Type="Allelic variant" ID="191092.0004" DB="OMIM" />
        <XRef Type="rs" ID="137854337" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000548.5(TSC2):c.2056_2059dup (p.Ser687fs) AND Tuberous sclerosis 2" Accession="RCV000013203" Version="23">
        <ClassifiedConditionList TraitSetID="3366">
          <ClassifiedCondition DB="MedGen" ID="C1860707">Tuberous sclerosis 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1997-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000548.5(TSC2):c.2056_2059dup (p.Ser687fs) AND Tuberous sclerosis syndrome" Accession="RCV000043367" Version="3">
        <ClassifiedConditionList TraitSetID="8139">
          <ClassifiedCondition DB="MedGen" ID="C0041341">Tuberous sclerosis syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no classification provided</ReviewStatus>
            <Description SubmissionCount="1">not provided</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1997-12-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2013-09-16">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">1870099</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">4461062</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">7823706</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9361032</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8139" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="15993" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Tuberous sclerosis syndrome</ElementValue>
                <XRef ID="7199000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tuberous sclerosis</ElementValue>
                <XRef ID="MONDO:0001734" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TSC</ElementValue>
                <XRef Type="MIM" ID="191100" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">TS</ElementValue>
                <XRef Type="MIM" ID="191100" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7830" />
                <XRef ID="7830" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Tuberous sclerosis complex (TSC) involves abnormalities of the skin (hypomelanotic macules, confetti skin lesions, facial angiofibromas, shagreen patches, fibrous cephalic plaques, ungual fibromas); brain (subependymal nodules, cortical tubers, and subependymal giant cell astrocytomas [SEGAs], seizures, intellectual disability / developmental delay, psychiatric illness); kidney (angiomyolipomas, cysts, renal cell carcinomas); heart (rhabdomyomas, arrhythmias); and lungs (lymphangioleiomyomatosis [LAM], multifocal micronodular pneumonocyte hyperplasia). Central nervous system tumors are the leading cause of morbidity and mortality; renal disease is the second leading cause of early death.</Attribute>
                <XRef ID="NBK1220" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301399</ID>
                <ID Source="BookShelf">NBK1220</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_TuberousSclerosis.pdf</URL>
                <CitationText>Orphanet, Tuberous sclerosis, 2007</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <XRef ID="805" DB="Orphanet" />
              <XRef ID="C0041341" DB="MedGen" />
              <XRef ID="MONDO:0001734" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS191100" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3366" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6897" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Tuberous sclerosis 2</ElementValue>
                <XRef ID="Tuberous+sclerosis%2C+type+2/7257" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013199" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">TSC2</ElementValue>
                <XRef Type="MIM" ID="613254" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15640" />
                <XRef ID="15640" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5381" />
                <XRef ID="5381" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Tuberous sclerosis complex (TSC) involves abnormalities of the skin (hypomelanotic macules, confetti skin lesions, facial angiofibromas, shagreen patches, fibrous cephalic plaques, ungual fibromas); brain (subependymal nodules, cortical tubers, and subependymal giant cell astrocytomas [SEGAs], seizures, intellectual disability / developmental delay, psychiatric illness); kidney (angiomyolipomas, cysts, renal cell carcinomas); heart (rhabdomyomas, arrhythmias); and lungs (lymphangioleiomyomatosis [LAM], multifocal micronodular pneumonocyte hyperplasia). Central nervous system tumors are the leading cause of morbidity and mortality; renal disease is the second leading cause of early death.</Attribute>
                <XRef ID="NBK1220" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301399</ID>
                <ID Source="BookShelf">NBK1220</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="Orphanet, 2007">
                <URL>https://www.orpha.net/data/patho/Pro/en/Emergency_TuberousSclerosis.pdf</URL>
                <CitationText>Orphanet, Tuberous sclerosis, 2007</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23519317</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="805" DB="Orphanet" />
              <XRef ID="C1860707" DB="MedGen" />
              <XRef ID="MONDO:0013199" DB="MONDO" />
              <XRef Type="MIM" ID="613254" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="33450" SubmissionDate="2013-03-15" DateLastUpdated="2013-04-04" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="191092.0004_TUBEROUS SCLEROSIS 2" title="TSC2, 4-BP INS, 2077TACT_TUBEROUS SCLEROSIS 2" />
        <ClinVarAccession Accession="SCV000033450" DateUpdated="2013-04-04" DateCreated="2013-04-04" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1997-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Yates et al. (1997) investigated the family in which 3 sibs with tuberous sclerosis (613254) had unaffected parents. Polymorphic markers showed that different maternal and paternal haplotypes in affected children excluded TSC1 as the cause of the disease; on the other hand, for the TSC2 markers, all the affected children had the same maternal and paternal haplotypes, as did 3 of their unaffected sibs. Mutation screening by RT-PCR and direct sequencing of the TSC2 gene identified a 4-bp insertion (TACT) following nucleotide 2077 in exon 18 in the 3 affected children but not in 5 unaffected sibs or the parents. This mutation would cause a frameshift and premature termination at codon 703. Absence of the mutation in lymphocyte DNA from the parents was consistent with germline mosaicism and this was confirmed by finding identical chromosome 16 haplotypes in affected and unaffected sibs, providing unequivocal evidence for 2 different cell lines in the gametes. Molecular analysis of the TSC2 alleles present in affected subjects showed that the mutation had been inherited from the mother. This was the first case of germline mosaicism in tuberous sclerosis proven by molecular genetic analysis and also the first example of female germline mosaicism for a characterized autosomal dominant gene mutation apparently not associated with somatic mosaicism. The sibship from northern Ireland had 9 children; 3 of the 6 unaffected sibs had the identical chromosome 16 haplotype as the affected sibs, derived from the mother. Yates et al. (1997) stated that nonpenetrance in 1 of the parents and the 3 unaffected children with the high risk haplotype is highly improbable; there was only 1 reported family where this was a possibility (Webb and Osborne, 1991). Yates et al. (1997) suggested that germline mosaicism was first postulated by Bowen (1974) to explain the occurrence of the fully penetrant condition achondroplasia in 2 sisters born to normal parents. Since that time, germline mosaicism had been established by molecular means in several disorders. In tuberous sclerosis, 1 case of proven somatic mosaicism had been reported (Verhoef et al., 1995).</Attribute>
              <Citation>
                <ID Source="PubMed">9361032</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">1870099</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">4461062</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">7823706</ID>
              </Citation>
              <XRef DB="OMIM" ID="613254" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TSC2" />
          </GeneList>
          <Name>TSC2, 4-BP INS, 2077TACT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP INS, 2077TACT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="191092.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TUBEROUS SCLEROSIS 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="115349" SubmissionDate="2013-08-09" DateLastUpdated="2013-09-16" DateCreated="2013-05-03">
        <ClinVarSubmissionID localKey="TSC2_00062_TSC" title="NM_000548.3:c.2056_2059dup AND TSC" />
        <ClinVarAccession Accession="SCV000067173" DateUpdated="2013-09-16" DateCreated="2013-05-03" Type="SCV" Version="3" SubmitterName="Tuberous sclerosis database (TSC2)" OrgID="500074" OrganizationCategory="locus-specific database (LSDB)" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Tuberous Sclerosis Database Assertion Criteria 2015</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/krkkw3ff/tuberous_sclerosis_database_assertion_criteria_2015.docx</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles">1</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TSC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>Exon 18</GeneLocation>
          </Location>
          <CitationList>
            <Citation Type="general">
              <ID Source="PubMed">9361032</ID>
            </Citation>
          </CitationList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000548.3:c.2056_2059dup</Attribute>
          </AttributeSet>
          <AttributeSet>
            <Attribute Type="HGVS">p.(Ser687Leufs*17)</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">TSC</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="33450" TraitType="Disease" MappingType="Name" MappingValue="TUBEROUS SCLEROSIS 2" MappingRef="Preferred">
        <MedGen CUI="C1860707" Name="Tuberous sclerosis 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="115349" TraitType="Disease" MappingType="Name" MappingValue="TSC" MappingRef="Preferred">
        <MedGen CUI="C0041341" Name="Tuberous sclerosis syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

